Previous 10 | Next 10 |
REDWOOD CITY, Calif. , April 21, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the f...
In a unanimous opinion, an appeals court ruled in favor of all of Nevro's (NYSE: NVRO ) asserted claims covering methods and systems for delivering spinal cord stimulation (SCS) therapy at high frequencies. More news on: Nevro Corp., Boston Scientific Corporation, Healthcare stocks news,...
REDWOOD CITY, Calif. , April 9, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that in its patent litigation against Boston Scientific the U....
REDWOOD CITY, Calif. , April 3, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the underwriter of each of Nevro's previously a...
Luckin Coffee (NASDAQ: LK ) -84% on fraud finding . More news on: Luckin Coffee Inc., Golar LNG Partners LP, Safe-T Group Ltd, Stocks on the move, , Read more ...
Nevro (NYSE: NVRO ) has priced its public offerings of ~1.6M common shares at $84.00 per share for gross proceeds of ~$136.5M and $165M 2.75% convertible senior notes due 2025. More news on: Nevro Corp., Healthcare stocks news, , Stocks on the move, Read more ...
REDWOOD CITY, Calif. , April 2, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the pricing of concurrent underwritten public offerings o...
On a preliminary basis, Nevro (NYSE: NVRO ) expects Q1 revenue of $86.4M - 86.9M, below consensus of $97M. The company cites a rapid deceleration in March due to COVID-19 for the shortfall. More news on: Nevro Corp., Healthcare stocks news, Earnings news and commentary, , Stocks on the m...
REDWOOD CITY, Calif. , April 1, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has commenced a proposed underwritten public...
Nevro (NYSE: NVRO ) reports preliminary Q1 2020 revenue is expected to be ~$86.4M - $86.9M, up 5-6% Y/Y; says Q1 revenue was negatively impacted by a rapid deceleration in March due to COVID-19 shelter-in-place policies and restrictions on elective surgical procedures More news on: Nevro C...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...